As previously reported by BioSpace, a group of scientists from the Babraham Institute in the United Kingdom was able to successfully rejuvenate skin cells by a full 30 years.
Novavax Inc.’s shares plunged nearly 20 percent in premarket trading on May 10 due to uncertainty over global demand for the company’s COVID-19 vaccine following a slow start to deliveries.
Checkpoint inhibitor pioneer James P. Allison, who won the 2018 Nobel Prize in Medicine, will helm a new research and innovation hub at The University of Texas MD Anderson Cancer Center that is focused on developing new immunotherapy breakthroughs in oncology.
Research Roundup: Spider Silk Stabilizes Cancer-Suppressing Protein and More
Asthma, Autism Spectrum Disorder (ASD), Cancer Cells, Cancer Therapies, Coronavirus Disease 2019 (COVID-19), Gene Mutations, Heart Attacks, Heart Disease, High Cholesterol, Karolinska Institute, Medical Journals, Parkinson's Disease, Pediatrics, Proteins, R&D, Skin test, Structure, TestingMaybe Spider-Man was on to something. Although spider silk and synthetic forms have been used for a wide range of applications – including bullet-proof clothing, biodegradable bottles, and bandages and surgical thread – new research suggests it may have a use for cancer therapies.
The U.S. Patent and Trademark Office ruled that the use of CRISPR-Cas9 in humans belongs to the Broad Institute of Massachusetts Institute of Technology, not the University of California, Berkeley.
After allegations of bullying became public, Dr. Eric Lander – the director of the federal government’s Office of Science and Technology Policy – resigned from his executive branch role.
Novavax, after delays, files for U.S. authorization of COVID-19 vaccine
Adults, Business, COVAX Facility, Covid-19 Data, COVID-19 Vaccines, Covid-19 Variants, Delta Variant (B.1.617.2; India), Emergency Use Authorization (EUA), Facilities/Sites/Manufacturing, FDA, Mexico, Novavax, Omicron (B.1.1.529) (South Africa), R&D, Serum Institute of India, United Kingdom, United States, World Health OrganizationNovavax Inc. filed for emergency use authorization of the company’s COVID-19 vaccine for U.S. adults, a long-awaited step following months of struggles with development and manufacturing problems.
Novavax Inc. said on Oct. 27 the company had completed the real-time submission of an application for the authorization of the Covid-19 vaccine candidate NVX-CoV2373 in the United Kingdom.
The Novo Nordisk Foundation is partnering with the Broad Institute of MIT and Harvard University to launch a massive genetic data mining project that aims to gain deeper insight into how human genetic variants affect risk for common complex diseases.
Although it’s difficult, when faced with a cancer diagnosis, it’s important to find the best health care facility to receive treatment. Improving the future of cancer tech, this posting looks at some of the most high-tech cancer hospitals in America.